Abbott Laboratories is a diversified healthcare supplier with a focus on medical devices, nutrition, diagnostics, and pharmaceuticals. The company experienced a surge in share price due to COVID-19 ...

Abbott Laboratories (ABT 0.01%) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the ...

Abbott Laboratories reported strong Q4 2023 earnings, with year-over-year growth in EPS and revenue. The company's 2024 guidance projects further growth and improved ...

A new automation system from Abbott, designed to improve workflows in clinical lab settings, has been granted FDA approval. The system, GLP systems Track, uses a self-propelled carrier system that ...

A concussion test that Abbott Labs hopes someday could be used by sports team trainers and at urgent care clinics is now available for rapid use at the bedside, without having to send a sample to a ...

Sales at Abbott Laboratories' diagnostics unit dropped in the second quarter as demand for COVID-19 tests slumped. The company beat profit and sales estimates on strong sales of its medical devices.

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...